Florian Fuchs

Florian Fuchs

Auto-generated profile, based on publicly available information

Florian Fuchs

Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SCSrinivas Niranj Chandrasekaran
Srinivas Niranj Chandrasekaran
JAJeanelle Ackerman
Jeanelle Ackerman
EAEric Alix
Eric Alix
DAD. Michael Ando
D. Michael Ando
JAJohn Arevalo
John Arevalo
ACAnne E. Carpenter
Anne E. Carpenter
Image-based profiling decodes complex cellular states for high-impact biological and therapeutic applications, yet a large, public reference dataset of chemical perturbations has been lacking. We present Cell Painting images and 1.53 billion single-cell profiles for 115,796 compounds in human osteosarcoma cells, generated by the Joint Undertaking for Morphological Profiling (JUMP)-Cell Painting Consortium of 18 industry and non-profit partners. Despite technical variability across 12 data-generating laboratories, more than 15% of compounds show statistically significant phenotypic activity, reproducibility drops only 34% versus single-laboratory data, and compounds sharing biological targets often show similar image-based profiles. JUMP establishes a validated public reference resource that brings image-based profiling on par with genomics and transcriptomics. The dataset, shared alongside previously released genetic perturbation data in the Cell Painting Gallery, is a powerful predictive engine for the impact, mechanism, targets and activities of compounds, fundamentally accelerating chemical and cell biology and early-stage drug development.

7 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
YFYue Fu
Yue Fu
DEDavid Estoppey
David Estoppey
SRSilvio Roggo
Silvio Roggo
DPDominik Pistorius
Dominik Pistorius
FFFlorian Fuchs
Florian Fuchs
DHDominic Hoepfner
Dominic Hoepfner
Biosynthesis of glycosylphosphatidylinositol (GPI) is required for anchoring proteins to the plasma membrane, and is essential for the integrity of the fungal cell wall. Here, we use a reporter gene-based screen in Saccharomyces cerevisiae for the discovery of antifungal inhibitors of GPI-anchoring of proteins, and identify the oligocyclopropyl-containing natural product jawsamycin (FR-900848) as a potent hit. The compound targets the catalytic subunit Spt14 (also referred to as Gpi3) of the fungal UDP-glycosyltransferase, the first step in GPI biosynthesis, with good selectivity over the human functional homolog PIG-A. Jawsamycin displays antifungal activity in vitro against several pathogenic fungi including Mucorales, and in vivo in a mouse model of invasive pulmonary mucormycosis due to Rhyzopus delemar infection. Our results provide a starting point for the development of Spt14 inhibitors for treatment of invasive fungal infections.

18 January 2021 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
GSGabi Schutzius
Gabi Schutzius
CKChristian Kolter
Christian Kolter
SBSebastian Bergling
Sebastian Bergling
FTFederico Tortelli
Federico Tortelli
FFFlorian Fuchs
Florian Fuchs
SKSusan Kirkland
Susan Kirkland

31 July 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
YFYue Fu
Yue Fu
DEDavid Estoppey
David Estoppey
SRSilvio Roggo
Silvio Roggo
DPDominik Pistorius
Dominik Pistorius
FFFlorian Fuchs
Florian Fuchs
DHDominic Hoepfner
Dominic Hoepfner
An amendment to this paper has been published and can be accessed via a link at the top of the paper.